CRISTIAN RIVERA FOUNDATION REACHES $400,000 MILESTONE IN RECORD-BREAKING GIFT TO ADVANCE DIPG RESEARCH AT WEILL CORNELL MEDICINE

Kenan Thompson joins  founder John “Gungie” Rivera in celebrating a tenfold increase in annual giving since 2011, supporting pioneering research in DIPG.

What began with a $40,000 donation in 2011 has grown into an extraordinary partnership in the fight against childhood brain cancer. Actor and comedian Kenan Thompson joined Cristian Rivera Foundation (CRF) Founder and President John “Gungie” Rivera in presenting a record-breaking $402,175 donation to Dr. Mark Souweidane and the Children’s Brain Tumor Project at Weill Cornell Medicine. The gift represents a 10% increase over last year’s contribution and a tenfold increase since the Foundation’s first investment in Dr. Souweidane’s DIPG research.

Founded by Rivera in memory of his six-year-old son, Cristian, the Foundation continues to be the most steadfast supporter of Dr. Souweidane’s pioneering work to develop innovative treatments for this terminal pediatric brain tumor. Thompson, a longtime CRF Board Member, has played a prominent role in helping raise awareness and support for the Foundation’s mission.

The partnership has helped sustain an ambitious research program that began with a groundbreaking clinical trial in 2011, investigating the direct delivery of therapeutic agents into these inoperable brainstem tumors. Among the patients treated in that early trial are three remarkable long-term survivors, who have survived and thrived for more than five years following their diagnoses.

Building on that early work, Dr. Souweidane and his team have continued to advance novel therapeutic approaches. With sustained philanthropic support from CRF and other dedicated partners, the program has advanced the development of nine clinical trials and contributed to more than 35 scientific publications that increase our understanding and treatment of DIPG and diffuse midline glioma, reflecting more than a decade of sustained scientific investigation.

‘When I lost my son Cristian to DIPG, I promised to do everything in my power to find a cure and spare other families that heartbreak. What began as a $40,000 donation to Dr. Souweidane’s research has grown to $400,000, thanks to our incredible supporters. Every dollar brings us closer to fulfilling my promise to Cristian, and we’ll keep moving full steam ahead until we find a cure,” said Rivera.

“Scientific progress requires more than promising ideas. It requires the resources and commitment to pursue them over many years,” said Dr. Souweidane. “The Cristian Rivera Foundation has stood beside us for more than 15 years, helping us advance new treatments from the laboratory into clinical trials and contributing to progress that includes extraordinary long-term survivors.”

For more than 15 years, Rivera’s determination to honor Cristian has translated into an enduring investment in scientific progress. What began as a father’s mission to find a cure has grown into a powerful partnership that continues to push the boundaries of what may be possible for children diagnosed with DIPG.

To learn more about the Cristian Rivera Foundation and to support its mission, visit cristianriverafoundation.org.